NAMI's National Director of Government Relations and Policy, Jennifer Snow, MPA, explains how advocates rallied in support of ...

CKD patients face higher CVD risk, with dyslipidemia differing from the general population, necessitating tailored lipid ...

Infant protection against respiratory syncytial virus (RSV) by maternal RSV vaccination or receipt of RSV monoclonal antibody ...

In a cohort of young adults with metastatic colorectal cancer (mCRC), 3-year survival was lowest among Black patients and ...

Panelists discuss how addressing payer restrictions and leveraging data-driven advocacy are essential for timely access to ...

Panelists discuss how identifying candidates for anti-amyloid therapy requires precise evaluation of disease stage, cognitive ...

More representative trial populations and standardized subgroup reporting are needed in non–small cell lung cancer (NSCLC) research, according to a meta-analysis published in Cancers, which found no ...

Panelists discuss how integrating novel treatments with psychosocial support can improve adherence and empower patients toward recovery. Panelists discuss how sustained efforts to reduce stigma and ...

Approximately $2 billion in grants were canceled, undermining bipartisan efforts to strengthen the behavioral health system ...

"The Great Healthcare Plan" aims to lower drug costs, reduce premiums, and enhance price transparency, with a focus on Most ...

The result is that value-based care now suffers from a branding problem. The term has come to mean everything and nothing at ...

CheckMate 9LA showed a 26% overall survival benefit for metastatic NSCLC patients treated with nivolumab and ipilimumab plus ...